comparemela.com

Kura Oncology, Inc. (NASDAQ:KURA – Get Free Report) has been assigned a consensus recommendation of “Moderate Buy” from the seven ratings firms that are currently covering the firm, MarketBeat reports. One research analyst has rated the stock with a hold recommendation and six have given a buy recommendation to the company. The average twelve-month price […]

Related Keywords

Teresa Brophy Bair ,Nasdaq ,Sg Americas Securities ,Fund Management Co ,Kura Oncology Company Profile ,E Fund Management Co ,Securities Exchange Commission ,Kura Oncology Inc ,Kura Oncology ,Get Free Report ,Exchange Commission ,Fire Capital ,Fund Management ,Get Free ,Kura Oncology Daily ,

© 2024 Vimarsana

comparemela.com © 2020. All Rights Reserved.